Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Debt Issuance
confidence 75%
filed 2026-06-16
The 6-K discloses an amendment and waiver agreement executed on June 15, 2026, modifying the terms of senior convertible notes previously issued in February 2026. The amendment increased the aggregate principal amount from $4,347,826.08 to $4,987,489 and reduced the conversion price to $0.57 per share. While the original note issuance occurred in February, this June amendment materially alters the debt obligation and dilutive conversion terms, warranting disclosure as a material debt-related event. The reduction in conversion price is particularly dilutive to existing shareholders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This 8-K Item 5.07 discloses the results of the Company's 2026 Annual Meeting of Shareholders held on June 12, 2026, including tabulated voting results for three proposals: election of five directors, ratification of the independent auditor (Hacker, Johnson & Smith, P.A.), and advisory approval of named executive officer compensation. The filing presents vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-16
Item 1.01
The filing discloses a "Change of Control Agreement" (Exhibit 10.1) effective June 9, 2026, involving EQUORIX LLC acquiring control of Hallmark Venture Group through an 8% Convertible Promissory Note (Exhibit 4.1). The company explicitly states it ceased to be a "shell company" as of the closing of this Control Agreement (Item 5.06), and the shareholding table shows David Lee/EQUORIX LLC holding 90.80% of common stock and 100% voting power via Series A Preferred Stock. This constitutes a material change of control transaction requiring disclosure under Item 1.01.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 92%
filed 2026-06-16
The filing discloses results of the 2026 Annual Meeting of Stockholders held on June 16, 2026, including voting outcomes on four proposals: election of Class I directors (Proposal 1), ratification of auditor WithumSmith + Brown, PC (Proposal 2), advisory Say-on-Pay vote on 2025 executive compensation (Proposal 3), and approval of an amendment to the 2018 Stock Incentive Plan increasing authorized shares by 1,000,000 (Proposal 4). Item 5.07 explicitly presents the voting results with vote counts for each matter, which is the hallmark disclosure of shareholder vote results under Item 5.07.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-16
Item 8.01
Ocean Capital Acquisition Corp disclosed the consummation of its IPO on June 10, 2026, raising $115 million in gross proceeds from the sale of 11.5 million units at $10.00 per unit, plus a concurrent private placement of 150,000 units for $1.5 million. While this is a material capital-raising event affecting the registrant's financial position, it does not fit neatly into the earnings_release category (which typically refers to periodic financial results) or any other more specific event type. The disclosure is material to investors as it establishes the company's initial capitalization and trust account structure for a SPAC.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-16
Item 8.01
Bandwidth Inc. announced a private offering of $275 million principal amount of 0% convertible senior notes due 2032 pursuant to Rule 144A. Convertible notes are inherently dilutive securities that will likely convert to equity, representing a material capital raise that would affect investor assessment of the company's capitalization and ownership structure.
View raw filing on EDGAR →
8-K
Other material
confidence 70%
filed 2026-06-16
Item 1.01
Matador Resources amended its secured revolving credit facility to increase aggregate elected borrowing commitments from $2.25 billion to $2.75 billion, while maintaining the borrowing base at $3.25 billion. This refinancing modification enhances the company's liquidity and financial flexibility.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Matador Resources held its Annual Meeting of Shareholders on June 11, 2026, with shareholders voting on three proposals: election of three Class III directors (Foran, Baribault, Parker), advisory approval of 2025 named executive officer compensation, and ratification of KPMG LLP as independent auditor. All three proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-06-16
Item 5.02
Stephen Reitman, a director of Capri Holdings Limited, has expressed his intention not to stand for re-election to the Board, with his term ending at the conclusion of the 2026 Annual Meeting on July 29, 2026. This constitutes a departure of a director from the Board. While the disclosure notes his retirement is not due to disagreement with the Company, the material fact is the loss of a board member, which is typically material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-16
Item 8.01
The disclosure announces advancement of AVTX-010, a clinical-stage therapeutic candidate, into development for hidradenitis suppurativa and additional inflammatory disorders. While this represents material clinical progress for a biopharmaceutical company, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, or litigation). The advancement of a lead candidate into new indications is material to investors assessing the company's pipeline and development strategy, warranting classification as other_material.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-16
Item 8.01
This disclosure describes the entry into underwriting and certificate purchase agreements for a commercial mortgage-backed securities (CMBS) offering by BMO 2026-5C15 Mortgage Trust, with public certificates of $553.4 million and private certificates of $72.8 million scheduled to close on June 25, 2026. While this represents a material financing/securitization transaction, it does not fit cleanly into the ma_activity category (which typically covers acquisitions, dispositions, mergers, or changes of control of the registrant itself) nor any other more specific event type. The offering is material to investors as it represents the primary business activity and capital structure of this mortgage trust, but the taxonomy lacks a dedicated securitization or debt issuance category.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-16
Item 8.01
This Item 8.01 disclosure announces the issuance of commercial mortgage pass-through certificates (BANK 2026-BNK52) on July 7, 2026, backed by a pool of 70 commercial, multifamily, and manufactured housing mortgage loans. While this is a material securitization transaction involving multiple underwriters and a substantial asset pool, it does not fit neatly into the standard M&A taxonomy categories—it is a structured finance issuance rather than a traditional acquisition, merger, or disposition. The disclosure is material to investors as it represents a significant capital markets transaction and commitment of assets, but the event type is best classified as "other_material" given the specialized nature of mortgage-backed securities issuance.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 92%
filed 2026-06-16
YPF reports completion of a share repurchase program approved by the Board of Directors, acquiring 461,311 Class D ordinary shares between June 8–12, 2026, for a total of Ps. 38.4 billion. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category. The materiality and scale of the transaction (nearly 40 billion pesos) would affect a reasonable investor's assessment of capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-16
YPF repurchased Class XXX Notes (YMCWO) totaling approximately US$14.9 million in par value between June 8–12, 2026. While technically a repurchase rather than a new issuance, this represents a material modification of the Company's direct financial obligations—the notes were originally issued in July 2024 and April 2025 with July 2026 maturity. The repurchase at 99.93% of par value is a significant capital deployment affecting the Company's debt structure and liquidity position, warranting disclosure as a material financial event. The closest taxonomy fit is debt_issuance, which encompasses creation and modification of direct financial obligations; alternatively, this could be classified as financial_other (debt reduction/retirement), but the materiality and scale (US$14.9M) support the debt-related classification.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-16
Item 8.01
The Company disclosed an unsolicited mini-tender offer by MacKenzie Capital Management to purchase up to 150,000 shares (0.2% of outstanding stock) at $7.27 per share, with the Company announcing neutrality on June 16, 2026. While mini-tender offers are typically routine disclosures, this event is material to shareholders as it affects their investment decisions and the total mix of information available. The disclosure does not fit neatly into more specific categories (not a shareholder vote, not a going-concern issue, not litigation), making "other_material" the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from Intensity Therapeutics' June 16, 2026 annual meeting of stockholders. The filing presents final voting tallies for five proposals: election of two Class III directors (Dr. Emer Leahy and Lewis H. Bender), ratification of EisnerAmper LLP as independent auditor, approval of amendments to the 2021 Stock Incentive Plan and 2024 Employee Stock Purchase Plan, and approval of potential adjournment. All proposals passed with majority support. This is a material event as it reflects stockholder approval of key governance and compensation matters.
View raw filing on EDGAR →
8-K
Exec departure
confidence 85%
filed 2026-06-16
Item 5.02
Jim H. Snabe, a director and special advisor to the CEO, is taking a leave of absence from the Board effective immediately due to his appointment as Special Envoy to the European Commission for Industrial Artificial Intelligence. While framed as a temporary leave, the disclosure states he will not stand for re-election at the 2026 annual meeting and will have no voting or advisory duties during the absence, effectively removing him from active governance. The Board reduced its size from twelve to eleven directors, signaling a material change in board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This 8-K Item 5.07 discloses the results of DigitalOcean's 2026 Annual Meeting of Stockholders held on June 15, 2026, including voting outcomes on three proposals: election of directors (Warren Adelman and Pueo Keffer as Class II directors), ratification of PricewaterhouseCoopers LLP as independent auditor, and non-binding advisory approval of named executive officer compensation. The filing presents final vote tallies for each proposal, which is the core disclosure required under Item 5.07 for shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-06-16
Item 5.07
Shopify held its 2026 annual general meeting of shareholders on June 16, 2026, with voting results disclosed covering four matters: election of 10 directors, appointment of PricewaterhouseCoopers LLP as auditors, a non-binding say-on-pay vote on executive compensation, and a shareholder proposal on AI policy. The filing presents detailed vote tallies for each matter.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
Natera held its Annual Meeting of Stockholders on June 11, 2026, with shareholders voting on five proposals: election of directors, ratification of auditors, advisory vote on executive compensation, frequency of compensation votes, and approval of an amendment to the Amended and Restated 2015 Equity Incentive Plan increasing shares reserved by 3.2 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-16
Item 2.02
California Resources Corp disclosed results of operations and financial condition for a completed fiscal period, consistent with a quarterly or annual earnings announcement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-16
Item 8.01
California Resources Corporation announced a private offering of $550 million in senior notes due 2035. While this is a debt issuance rather than an equity issuance, it represents a material capital-raising activity that would affect a reasonable investor's assessment of the company's capital structure and financial obligations. The substantial principal amount and fixed coupon rate (7.250%) are material to the registrant's financial position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-06-16
Item 1.01
Space Exploration Technologies Corp. entered into an Agreement and Plan of Merger on June 16, 2026, to acquire Anysphere, Inc. (Cursor) for an implied equity value of $60.0 billion through a merger with a wholly owned subsidiary, with Cursor shareholders receiving Class A common stock consideration.
View raw filing on EDGAR →
8-K
Other material
confidence 75%
filed 2026-06-16
Item 8.01
Acumen announced the nomination of two enhanced brain delivery (EBD) development candidates for Alzheimer's disease and exercised its option to license and develop them under its JCR collaboration agreement, combining the company's AβO-selective antibody expertise with JCR's J-Brain Cargo blood-brain-barrier technology. Preclinical data demonstrated enhanced brain penetration (14-40x higher antibody levels in non-human primates) and favorable safety profiles, representing a material advancement in the company's pipeline and strategic positioning.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
Mr. W. Anthony (Tony) Will was appointed as a non-management Director of CRH PUBLIC LTD CO effective July 1, 2026, with the Board increasing from 12 to 13 members. The appointment was announced via press release on June 16, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-06-16
Item 7.01
The filing discloses a press release announcing "updated guidance for the quarter ended June 30, 2026," which constitutes forward-looking financial information material to investors' assessment of the company's expected performance. While technically disclosed under Item 7.01 (Regulation FD Disclosure) rather than Item 2.02, the substance is guidance disclosure—a form of earnings-related announcement that would affect a reasonable investor's view of the registrant's financial trajectory.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
GeneDx Holdings Corp. appointed Mark Gardner as President, effective June 15, 2026, with a $530,000 base salary, 65% target bonus, and $2,000,000 in restricted stock units vesting over four years.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-16
EX-99.1
Aya Gold & Silver announces its inclusion in the VanEck Gold Miners ETF (GDX), effective June 19, 2026, following the ETF's quarterly rebalance. The company's CEO states this is "a significant corporate milestone" that will "enhance the liquidity and visibility of our shares while increasing awareness among a broader global investor base." This is a material operational/strategic milestone reflecting market recognition and improved capital-market access, though it does not fit the specific categories of M&A, earnings, executive changes, or financial obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-16
Item 2.02
John Wiley & Sons disclosed financial results for the fourth quarter and fiscal year ended April 30, 2026, via press release (Exhibit 99.1) and earnings conference call presentation materials (Exhibit 99.2) held on June 16, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The disclosure centers on the appointment of David M. Wisniewski as Chief Accounting Officer effective June 17, 2026, a material executive position responsible for accounting oversight. While the filing also includes compensatory details (base salary of $355,000, incentive awards, and equity grants valued at ~$700,000), the principal disclosed action is the appointment itself. The disclosure of Michael Kenning's transition from Interim CAO to Global Controller is secondary to the primary appointment event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from the June 10, 2026 Annual Meeting of Stockholders. The filing presents detailed vote tallies for Proposal 1 (election of eight directors) and Proposal 2 (ratification of BDO USA, P.C. as independent auditor), with votes for, against, abstentions, and broker non-votes itemized for each nominee and proposal. This is a quintessential Item 5.07 disclosure and is material because director elections and auditor ratification are fundamental governance matters affecting investor confidence in the company's leadership and financial oversight.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-16
Item 1.01
Precision Biosciences entered into a First Amendment to its Loan and Security Agreement with Banc of California on June 10, 2026, extending the maturity date of the Term Loan from June 30, 2027, to December 31, 2029. This amendment materially extends the Company's debt maturity and improves its liquidity runway.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder voting results from Omada Health's 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing reports final vote tallies for two proposals: (1) election of Sean Duffy and Trevor Fetter as Class I Directors, and (2) ratification of Deloitte & Touche LLP as independent auditor. Both proposals passed with substantial majorities. This is a routine but material shareholder governance event required under Item 5.07 of Form 8-K.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This 8-K Item 5.07 discloses the final voting results from SkinHealth Systems Inc.'s June 10, 2026 annual meeting of stockholders, including results on three proposals: election of nine directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. The filing presents detailed vote tallies (For, Against, Withheld, Abstentions, and Broker Non-Votes) for each proposal, which is the core content required by Item 5.07 for shareholder vote results.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-16
Item 8.01
Arvinas and Pfizer entered into a license agreement with Rigel for exclusive global development, manufacturing and commercialization rights for VEPPANU, which became effective on June 11, 2026 following HSR clearance. The transaction involves a $70 million upfront payment, up to $320 million in contingent milestone payments, and tiered royalties, representing a material disposition of development and commercialization rights that would significantly affect investor assessment of the company's asset portfolio and revenue streams.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder vote results from Datadog's June 15, 2026 Annual Meeting of Stockholders, covering four proposals: election of Class I directors (Olivier Pomel, Dev Ittycheria, Shardul Shah, and Ami Vora), advisory approval of named executive officer compensation, ratification of Deloitte & Touche LLP as independent auditor, and a failed shareholder proposal on simple majority voting. The detailed vote tallies for each proposal are the core content of Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This Item 5.07 disclosure reports the results of Black Stone Minerals' 2026 annual meeting of limited partners held on June 11, 2026, including voting outcomes for three proposals: election of twelve directors to the Board, ratification of Deloitte & Touche LLP as independent auditor, and non-binding advisory approval of named executive officer compensation. The detailed vote tallies for each proposal and nominee are the core content of the filing, directly matching the shareholder_vote_results event type.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-16
Item 5.07
This is a clear disclosure of shareholder vote results from Vaxcyte's June 15, 2026 Annual Meeting of Stockholders, covering three matters: election of three Class III directors (Olivier Brandicourt, Halley Gilbert, and Grant Pickering), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The filing provides vote tallies (for, against, withheld, abstain, broker non-votes) for each matter, which is the standard format for Item 5.07 disclosures.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-06-16
NatWest Group plc announced the completion of pricing for USD 1,250,000,000 in 4.983% Senior Callable Fixed-to-Fixed Reset Rate Notes due 2032, with proceeds to fund general banking business and closing scheduled for 18 June 2026. This is a material debt issuance creating a direct financial obligation.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-16
Item 2.03
This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint-and-several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details in the provided text, combined with the general explanatory tone, suggests this may be a routine periodic disclosure rather than a discrete material event triggering Item 2.03. Classified as other_material because the disclosure addresses material financial obligations but does not fit cleanly into covenant_breach or other specific event categories.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-16
Item 1.01
CEL-SCI Corporation completed a registered public offering of 2,500,000 shares of common stock at $1.00 per share, raising $2.5 million in gross proceeds. The offering was priced and closed on June 14-16, 2026, with proceeds designated for development and working capital.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 75%
filed 2026-06-16
Item 8.01
Forward Industries received a letter from Brera Holdings' counsel alleging violations of federal securities laws under Section 13(d)(3) of the Securities Exchange Act regarding undisclosed group formation and potential Rule 13d-5 violations. While Forward Industries disputes the contentions as meritless, the allegation of securities law violations by a third party constitutes a material regulatory/legal matter requiring disclosure. The forward-looking statements section further emphasizes legal and regulatory uncertainty as a material risk factor.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 92%
filed 2026-06-16
Item 8.01
The filing discloses a settlement agreement in the litigation Augenbaum v. Anson Investments Master Fund LP et al. in which the Company received aggregate settlement payments of $50,000,000 (minus plaintiff's counsel fees and expenses), with court approval on June 11, 2026. This represents a material litigation settlement that would affect a reasonable investor's assessment of the registrant's financial position and legal exposure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-06-16
Item 1.01
OXO entered into an exclusive, 20-year License and Research Collaboration Agreement with the University of Edinburgh granting worldwide rights to proprietary software tools and algorithms in marketing analytics and SaaS platforms. The agreement includes substantial financial commitments ($30,000 initial fee, $180,000 annually for three years, 2% running royalties, escalating maintenance fees, and 3% equity upon a qualified financing event), exclusive sublicensing rights, and long-term strategic partnership terms. While technically a licensing arrangement rather than a traditional M&A transaction, the exclusive nature, duration, financial materiality, and equity participation component constitute a material strategic transaction requiring Item 1.01 disclosure.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-16
Item 1.01
Applied Optoelectronics entered into a material credit line agreement with Shanghai Pudong Development Bank on June 11, 2026, doubling the credit facility from RMB 250 million to RMB 500 million to support working capital and general business operations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-16
Item 8.01
EquipmentShare.com announced a private offering of $1,050 million in senior secured second lien notes due 2034 to qualified institutional investors under Rule 144A and to non-U.S. persons under Regulation S. This unregistered debt issuance materially increases the company's leverage and financial obligations.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-16
Item 7.01
EquipmentShare.com disclosed an additional $555 million in borrowings under an asset-based revolving credit facility since March 31, 2026, representing a material change in the company's leverage and liquidity position.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-16
Item 8.01
EquipmentShare.com announced an upsized private offering of $1,350 million in senior secured second lien notes due 2034, representing a $300 million increase from the previously announced size. The notes were offered to qualified institutional investors under Rule 144A and to non-U.S. persons under Regulation S, both exemptions from registration. While technically debt rather than equity, this unregistered capital raise is material to investors assessing the company's financial structure and dilution of existing security holders' claims.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-16
Item 1.01
BrightSpire Capital entered into a definitive agreement to sell two industrial real properties (the "Net Lease 1 Investment") for $300 million, representing a material disposition of assets. The filing explicitly states this is a "Material Definitive Agreement" under Item 1.01, and the transaction involves a substantial real estate portfolio with a GAAP carrying value of approximately $239 million as of March 31, 2026. This is a material disposition that would significantly affect investor assessment of the company's asset base and strategic direction.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-06-16
Item 8.01
The disclosure centers on Lunai's regained compliance with Nasdaq's minimum bid price rule but explicitly details heightened delisting risk going forward. The company is now subject to a mandatory one-year Panel monitor with no cure period if it falls out of compliance again—a material change in listing status that would directly affect investor assessment. The language regarding automatic delist determination and loss of compliance flexibility signals elevated delisting risk despite the current compliance status.
View raw filing on EDGAR →